Centrosomal abnormality is common in and a potential biomarker for bladder cancer

Centrosomal abnormalities have been implicated in chromosomal segregation aberrations that result from the formation of multipolar mitotic spindles and lead to aneuploidy. Aneuploidy is a characteristic of neoplasia and underlies the development and progression of bladder cancer. Therefore, centrosomal abnormality may play a key role in urothelial tumor transformation. The purpose of our investigation was to determine whether centrosomal abnormalities are present in malignant urothelial cells, define the relationship between centrosomal abnormalities and aneuploidy and determine whether the presence of centrosomal abnormalities might be a potential diagnostic marker for bladder cancer. Bladder wash specimens obtained from patients with and without a history of urothelial carcinoma were analyzed for centrosomal abnormalities using an immunoassay with a γ‐tubulin antibody. FISH with centromeric probes for chromosomes 4 and 9 and DNA ploidy image analysis were performed to detect aneuploidy. Defective centrosomes were found in 40 of 45 bladder wash specimens from patients with bladder cancer but in none of the 10 samples from patients without it. A large percentage (69%) of grade 1 tumors were positive for centrosomal abnormalities, and these abnormalities were increasing in numbers and size in grade 2 (93%) and grade 3 (100%) specimens. Centrosomal abnormalities and numerical chromosomal aberrations frequently appeared concomitantly in the same malignant cells. All of the specimens showing aneuploidy also exhibited centrosomal abnormalities: centrosomal defects and aneuploidy occurred together in 80% of malignant bladder tumors, with an especially high percentage in higher‐grade tumors. The overall positivity of centrosomal abnormalities was higher than that of aneuploidy (88% vs. 80%), especially in grade 1 tumors (69% vs. 46%), whereas aneuploidy was strongly associated with grade 2 and grade 3 tumors. Centrosomal abnormalities are common in bladder cancer, even in low‐grade tumors, and strongly associated with cancer grade and aneuploidy, especially in high‐grade neoplasms. Centrosomal abnormalities appear to be intrinsic to aneuploidy and tumorigenesis and may be potential markers for early detection of bladder cancer. © 2003 Wiley‐Liss, Inc.

[1]  Erich A. Nigg,et al.  Centrosome aberrations: cause or consequence of cancer progression? , 2002, Nature Reviews Cancer.

[2]  W. Lingle,et al.  Centrosome amplification and the development of cancer , 2002, Oncogene.

[3]  Carol Reynolds,et al.  Centrosome amplification drives chromosomal instability in breast tumor development , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Ried,et al.  Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu , 2002, Oncogene.

[5]  M. Grollino,et al.  Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma. , 2001, European journal of cancer.

[6]  Masafumi Nakamura,et al.  Stepwise Progression of Centrosome Defects Associated with Local Tumor Growth and Metastatic Process of Human Pancreatic Carcinoma Cells Transplanted Orthotopically into Nude Mice , 2001, Laboratory Investigation.

[7]  L. Bubendorf,et al.  Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. , 2001, American journal of clinical pathology.

[8]  Y. A. Minamishima,et al.  Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. , 2001, Cancer genetics and cytogenetics.

[9]  G. Auer,et al.  Human Papillomavirus Infection, Centrosome Aberration, and Genetic Stability in Cervical Lesions , 2001, Modern Pathology.

[10]  L. Liotta,et al.  Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. , 2001, Cancer research.

[11]  D J O'Kane,et al.  A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. , 2000, The Journal of urology.

[12]  R. Jenkins,et al.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.

[13]  Jonathan J Ross,et al.  Ancillary methods for the detection of recurrent urothelial neoplasia , 2000, Cancer.

[14]  E. Schröck,et al.  Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations , 2000, Genes, chromosomes & cancer.

[15]  C. Ker,et al.  Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts , 2000, Hepatology.

[16]  W. Lingle,et al.  Altered centrosome structure is associated with abnormal mitoses in human breast tumors. , 1999, The American journal of pathology.

[17]  Masafumi Nakamura,et al.  Centrosome abnormalities in pancreatic ductal carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  H. Mori,et al.  Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. , 1999, Cancer research.

[19]  P. Duesberg,et al.  Genetic instability of cancer cells is proportional to their degree of aneuploidy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Jian Kuang,et al.  Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.

[21]  H Knecht,et al.  Centrosome defects and genetic instability in malignant tumors. , 1998, Cancer research.

[22]  J. Ingle,et al.  Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Katz,et al.  Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer , 1998, Oncogene.

[24]  H. Moch,et al.  Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. , 1997, Cancer research.

[25]  D. Johnston,et al.  DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[26]  R.C.E. van Velthoven,et al.  Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. , 1995, Human pathology.

[27]  Th. Boveri,et al.  The origin of malignant tumors , 1929 .